RxDoctor Payments Data

Ashlee Myers, APRN

Family · Port St Lucie, FLNPI 1760080766

Payments from drug & device makers

$1,446in general payments, 2019–2025

Across 80 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$319
  • Amgen$190
  • Lilly USA, LLC$175
  • AstraZeneca$163
  • Novo Nordisk$142
  • GSK$82
  • plus $376 from 14 others

What the payments were for

  • Food & beverage$1,446100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,446 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$134,182
Medicare patients
283
Services billed
1,566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$73,426
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$64,525
EliquisApixaban86$61,398
Budesonide ErBudesonide11$25,012
XareltoRivaroxaban27$19,986
FarxigaDapagliflozin Propanediol19$14,732
TradjentaLinagliptin16$11,642
JanuviaSitagliptin Phosphate13$10,831
PremarinEstrogens, Conjugated12$5,072
Naproxen15$3,344
Levothyroxine Sodium193$3,042
Atorvastatin Calcium299$2,828
Pantoprazole Sodium126$2,718
Memantine Hcl65$2,641
Potassium Chloride67$2,625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$142$73,42646 claims
PfizerEliquis, Premarin$38$66,47098 claims
GSKTrelegy Ellipta$82$64,52555 claims
Johnson & JohnsonXarelto$31$19,98627 claims
AstraZenecaFarxiga$163$14,73219 claims
MerckJanuvia$15$10,83113 claims
ANI Pharmaceuticals, Inc.Valsartan$17$74616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.

Other family in Port St Lucie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →